Publication | Open Access
<scp>l</scp>-Ascorbyl 2,6-dipalmitate inhibits biofilm formation and virulence in methicillin-resistant Staphylococcus aureus and prevents triacylglyceride accumulation in Caenorhabditis elegans
47
Citations
60
References
2017
Year
Antimicrobial ChemotherapyBacterial PathogensCaenorhabditis ElegansDrug ResistanceAnticarotenogenic PotentialAntimicrobial TherapyInfection ControlAntimicrobial ResistanceHealth SciencesAntimicrobial Drug DiscoveryMethicillin-resistant Staphylococcus AureusBiochemistryVirulence FactorPrevents Triacylglyceride AccumulationAntibacterial AgentAntimicrobial PharmacokineticsPresent StudyAntimicrobial CompoundMolecular MicrobiologyPharmacologyClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsMicrobiologyMedicine
In the present study, the antibiofilm, antipathogenic and anticarotenogenic potential of<sc>l</sc>-ascorbyl 2,6-dipalmitate (ADP) against methicillin-resistant<italic>Staphylococcus aureus</italic>(MRSA) has been evaluated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1